Finance

Lists
Outlook: 77.8% bullish·0.0% bearish
Go to analysis
BBIO:NASDAQ
BridgeBio Pharma Inc
US$65,35
+0,48%
(+0,31) 1D
US$65,35
0,00% (0,00)
After hours
Closed: 9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BBIO...
Open
US$65,04
High
US$65,94
Low
US$64,34
Mkt. cap
12,78 ຕື້
Avg. vol.
2,70 ລ້ານ
Volume
1,85 ລ້ານ
52-wk high
US$93,42
52-wk low
US$52,75
EPS
US$-3,57
Beta
0,97
Shares outstanding
195,49 ລ້ານ
No. of employees
1 ພັນ
Open
US$65,04
High
US$65,94
Low
US$64,34
Mkt. cap
12,78 ຕື້
Avg. vol.
2,70 ລ້ານ
Volume
1,85 ລ້ານ
52-wk high
US$93,42
52-wk low
US$52,75
EPS
US$-3,57
Beta
0,97
Shares outstanding
195,49 ລ້ານ
No. of employees
1 ພັນ
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
19 ຊົ່ວໂມງກ່ອນ
(BBIO) Price Dynamics and Execution-Aware Positioning
https://www.dars.gov.et/
https://www.dars.gov.et/
·
4 ມື້ກ່ອນ
BBIO Q2 2026 Earnings: Wider-Than-Expected Loss as EPS Misses Consensus by 31% - Guidance vs Actual
About BridgeBio Pharma Inc
CEONeil Kumar
Employees1 ພັນ
Founded2015
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websitebridgebio.com
Analyst ratings
Based on 17 analysts giving stock ratings to BBIO in the past 3 months
Strong buy
Buy
16
Hold
1
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for BBIO in the last 3 months.
Highest
Current US$65,35
US$156,00 (+138,71%)
Average
US$111,38 (+70,44%)
Lowest
US$94,00 (+43,84%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luca Issi
RBC Capital
Buy
Maintained
US$100,00
+53%
10/08/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
US$106,00
+62,2%
10/06/2026
Jason Zemansky
Bank of America Securities
Buy
Maintained
US$104,00
+59,1%
10/06/2026
Eliana Merle
Barclays
Buy
Maintained
US$156,00
+138,7%
10/07/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
10/06/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$120,00
+83,6%
10/06/2026
Tyler Van Buren
TD Cowen
Buy
Reiterated
US$110,00
+68,3%
09/24/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
US$130,00
+98,9%
09/14/2026
Salim Syed
Mizuho Securities
Buy
Maintained
US$110,00
+68,3%
08/31/2026
Andrew Tsai
Jefferies
Buy
Maintained
US$110,00
+68,3%
08/31/2026
Biren Amin
Piper Sandler
Buy
Maintained
US$115,00
+76%
08/31/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
US$110,00
+68,3%
08/29/2026
Eric Joseph
Citi
Hold
Maintained
US$94,00
+43,8%
08/12/2026
Anupam Rama
J.P. Morgan
Buy
Reiterated
US$111,00
+69,9%
08/12/2026
Danielle Brill
Truist Financial
Buy
Maintained
US$107,00
+63,7%
08/12/2026
Sean Laaman
Morgan Stanley
Buy
Reiterated
US$97,00
+48,4%
08/11/2026
Derek Archila
Wells Fargo
Buy
Reiterated
US$102,00
+56,1%
08/11/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
US$102,00
+56,1%
08/11/2026
Tiago Fauth
Raymond James
Buy
Maintained
US$98,00
+50%
06/17/2026
Martin Auster
Raymond James
Hold
Downgraded
-
-
05/26/2026
Unknown Analyst
Citi
Hold
Initiated
-
-
05/19/2026
William Pickering
Bernstein
Buy
Reiterated
US$114,00
+74,4%
05/08/2026
Paul Choi
Goldman Sachs
Buy
Maintained
US$116,00
+77,5%
05/08/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
05/02/2026
Lisa Walter
RBC Capital
Buy
Initiated
US$100,00
+53%
04/08/2026
Trevor Allred
Oppenheimer
Buy
Maintained
US$81,00
+23,9%
02/25/2026
Last report
10 ສ.ຫ. 2026
Fiscal period
Q2 2026
US$-0,78 / US$-0,58
-33,87%miss
Revenue / Est. (USD)
243,68 ລ້ານ / 219,71 ລ້ານ
+10,91%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
120,70 ລ້ານ
154,18 ລ້ານ
194,52 ລ້ານ
243,68 ລ້ານ
Cost of goods sold
6,56 ລ້ານ
8,11 ລ້ານ
9,94 ລ້ານ
15,05 ລ້ານ
Cost of revenue
6,56 ລ້ານ
8,11 ລ້ານ
9,94 ລ້ານ
15,05 ລ້ານ
Research and development expenses
112,87 ລ້ານ
116,42 ລ້ານ
126,64 ລ້ານ
149,45 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
137,62 ລ້ານ
158,08 ລ້ານ
163,90 ລ້ານ
186,26 ລ້ານ
Operating expense
250,50 ລ້ານ
274,50 ລ້ານ
290,53 ລ້ານ
335,71 ລ້ານ
Total operating expenses
257,06 ລ້ານ
282,61 ລ້ານ
300,47 ລ້ານ
350,76 ລ້ານ
Operating income
-136,36 ລ້ານ
-128,43 ລ້ານ
-105,96 ລ້ານ
-107,08 ລ້ານ
Other non operating income
16,46 ລ້ານ
11,82 ລ້ານ
4,25 ລ້ານ
5,59 ລ້ານ
EBT including unusual items
-186,48 ລ້ານ
-194,76 ລ້ານ
-166,56 ລ້ານ
-155,89 ລ້ານ
EBT excluding unusual items
-177,64 ລ້ານ
-183,62 ລ້ານ
-166,56 ລ້ານ
-155,89 ລ້ານ
Income tax expense
-1,54 ລ້ານ
-120,00 ພັນ
-
-
Effective tax rate
0,83%
0,06%
-
-
Other operating expenses
-
-
-
-
Net income
-182,74 ລ້ານ
-192,86 ລ້ານ
-164,04 ລ້ານ
-152,22 ລ້ານ
Net profit margin
-151,40%
-125,09%
-84,33%
-62,47%
Earnings per share
-0,72
-0,94
-0,84
-0,78
Interest and investment income
6,24 ລ້ານ
4,33 ລ້ານ
6,25 ລ້ານ
6,66 ລ້ານ
Interest expense
-48,15 ລ້ານ
-50,31 ລ້ານ
-52,82 ລ້ານ
-54,62 ລ້ານ
Net interest expenses
-41,91 ລ້ານ
-45,98 ລ້ານ
-46,57 ລ້ານ
-47,96 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-134,96 ລ້ານ
-127,00 ລ້ານ
-104,77 ລ້ານ
-106,03 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google